Cash Flow Statement

Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization Cost of Revenue EBIAT Gross Profit Leases Machine, Furnitures, Fixtures & Other Non-Current Receivables Other Gross PP&E Adjustments Other Gross PP&E Adjustments Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Net Receivables Refunds Shares Issued Shares Outstanding Shares Outstanding Short-Term Debt repayments

Ratios

Silence Therapeutics (SLN) Receivables - Other (2019)

Silence Therapeutics' Receivables - Other history spans 1 years, with the latest figure at $34714.6 for Q4 2019.

On a quarterly basis, Receivables - Other changed N/A to $34714.6 in Q4 2019 year-over-year; TTM through Dec 2019 was $34714.6, a N/A change, with the full-year FY2019 number at $34474.6, changed N/A from a year prior.
Receivables - Other hit $34714.6 in Q4 2019 for Silence Therapeutics.
Over the last five years, Receivables - Other for SLN hit a ceiling of $34714.6 in Q4 2019 and a floor of $34714.6 in Q4 2019.